HER2-Positive Breast Cancer | Dissecting the Decision: Clinical and Nursing Investigators Provide Practical Perspectives on Key Issues in HER2-Positive Breast Cancer

published 2 months ago by Dr Neil Love

Proceedings from the second in a 2-part nursing webinar series. Featuring perspectives from Ms Jamie Carroll and Dr Sara Hurvitz, including the following topics: Introduction (0:00) An Overview of Breast Cancer in 2021 Case: A premenopausal woman in her early 40s with ER-positive, HER2-positive, node-negative breast cancer — Laurie Matt Amaral, MD, MPH (3:17) Management of Localized HER2-Positive Breast Cancer (7:22) Case: A woman in her early 70s with clinical T4 ER/PR-negative, HER2-positive breast cancer —Dr Matt Amaral (11:35) Sequencing of Agents for Metastatic HER2-Positive Breast Cancer (14:57) Case: A woman in her early 70s with a 10-cm Grade III, ER/PR-negative, HER2-positive infiltrating ductal carcinoma and pleural metastases — Alan B Astrow, MD (30:30) Case: A woman in her mid-30s with heavily pretreated ER/PR-positive, HER2-positive breast cancer and bone metastases — Estelamari Rodriguez, MD, MPH (36:34) Systemic Treatment of Brain Metastases in Patients with HER2-Positive Breast Cancer (51:33) Case: A Middle Eastern woman in her early 40s with HER2-positive breast cancer and brain metastases — Yanjun Ma, MD (51:49) Case: A woman in her early 40s with ER/PR-negative, HER2-positive breast cancer with brain metastasis — Atif Hussein, MD, MMM (55:06) NCPD information and select publications

more episodes from Research To Practice | Oncology Videos